Goh, K. C., Novotny-Diermayr, V., Hart, S., Ong, L. C., Loh, Y. K., Cheong, A., . . . Wood, J. M. (2012). TG02, a novel oral multi-kinase inhibitor of CDKs, JAK2 and FLT3 with potent anti-leukemic properties. Leukemia, 26(2), 236-243. https://doi.org/10.1038/leu.2011.218
Chicago-Zitierstil (17. Ausg.)Goh, K C., et al. "TG02, a Novel Oral Multi-kinase Inhibitor of CDKs, JAK2 and FLT3 with Potent Anti-leukemic Properties." Leukemia 26, no. 2 (2012): 236-243. https://doi.org/10.1038/leu.2011.218.
MLA-Zitierstil (9. Ausg.)Goh, K C., et al. "TG02, a Novel Oral Multi-kinase Inhibitor of CDKs, JAK2 and FLT3 with Potent Anti-leukemic Properties." Leukemia, vol. 26, no. 2, 2012, pp. 236-243, https://doi.org/10.1038/leu.2011.218.
Achtung: Diese Zitate sind unter Umständen nicht zu 100% korrekt.